NEUROPACE, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NEUROPACE, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $829.00K, a 33.71% increase year-over-year.
- NEUROPACE, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $620.00K, a 17.42% increase year-over-year.
- NEUROPACE, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-06-30 was $528.00K, a 120.00% increase year-over-year.
- NEUROPACE, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2023-06-30 was $240.00K, a 64.65% decline year-over-year.
- NEUROPACE, INC. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $1.28M, a 14.36% increase from fiscal 2024.
- NEUROPACE, INC. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $1.12M, a 71.41% increase from fiscal 2023.
- NEUROPACE, INC. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $654.00K, a 26.85% decline from fiscal 2022.
- NEUROPACE, INC. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $894.00K, a 1.87% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $829.00K 10-Q · filed 2026-08-11 | |
| 2025-12-31 | $1.28M 10-K · filed 2026-03-03 | |
| 2025-06-30 | $620.00K 10-Q · filed 2026-08-11 | |
| 2024-12-31 | $1.12M 10-K · filed 2026-03-03 | |
| 2024-06-30 | $528.00K 10-Q · filed 2025-11-04 | |
| 2023-12-31 | $654.00K 10-K · filed 2025-03-04 | |
| 2023-06-30 | $240.00K 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $894.00K 10-K · filed 2024-03-05 | |
| 2022-06-30 | $679.00K 10-Q · filed 2023-11-06 | |
| 2021-12-31 | $911.00K 10-K · filed 2023-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |